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A Review of Hemoglobin and the Pathogenesis of Cerebral Vasospasm
R. Loch Macdonald, MD, and Bryce K.A. Weir, MD We believe that current experimental and clinical evidence can be most satisfactorily interpreted by assuming that oxyhemoglobin is the cause of cerebral vasospasm that follows subarachnoid hemorrhage. We review the pathogenetic mechanisms by which oxyhemoglobin affects cerebral arteries. The relative importance of each of these mechanisms in the genesis of vasospasm, the biochemical pathways of oxyhemoglobin-induced smooth muscle contraction, and the intracellular actions of oxyhemoglobin on smooth muscle and on other cells in arteries are still not definitely established. (Stroke 1991^2:971-982) C erebral vasospasm is an important cause of cerebral ischemia and death 1 " 3 following aneurysmal subarachnoid hemorrhage (SAH). Cerebral vasospasm is usually the most frequent serious complication in survivors of SAH, 1 -3 although recent reports show that with hypervolemic hypertensive therapy and calcium channel antagonists, morbidity and mortality from vasospasm may have become relatively less important. 4 Advances have also been made in identifying the spasmogen responsible for vasospasm and in defining how it causes arterial narrowing. Oxyhemoglobin (OxyHb) is probably the principal pathogenetic agent. 5 " 7 We review evidence supporting the theory that OxyHb causes vasospasm. This substance has many mechanisms of action that may be important in vasospasm. These include the release of free radicals 8 -9 ; the initiation and propagation of lipid peroxidation 9 ; metabolism to bilirubin, which is another potential spasmogen 10 -11 ; the release of vasoactive eicosanoids 12 and endothelin 13 from the vessel wall; perivascular nerve damage 14 -15 ; the inhibition of endothelium-dependent relaxation 16 ; and the induction of structural damage in the arterial wall. With time OxyHb is oxidized to methemoglobin, 91718 - 20 but further breakdown of heme to bilirubin occurs only in vivo. 617 - 24 The exact mechanisms by which heme groups of hemoglobin (Hb) are broken down into bilirubin are not known, but they probably require enzymes present only in living cells. 25 After SAH, RBCs remain fixed in the subarachnoid space for days and they disappear by hemoryzing, similar to the process in vitro. 17 -26 In 1944, Zucker 27 recognized that RBC cytosol was vasoactive although platelets and serum were much more potent vasoconstrictors. Further experiments have documented that RBCs contain a vasoactive substance that is released by hemolysis. Humans with clinically significant vasospasm on average have higher temperatures and more often have leukocytosis than patients with ruptured aneurysms without vasospasm. 38 In experimental animals, hemogenic meningitis, which may produce these changes, is due to the heme component of RBCs. 39 ' 40 Many investigators have assayed the vasoactivity of incubated and aged mixtures of whole blood, blood components, and cerebrospinal fluid (CSF) on dog and cat basilar arteries in vitro. [18] [19] [20] 41 Results are remarkably concordant between experiments and may be summarized as follows. Fresh serum, plateletrich plasma, and lysed RBCs have significant vasoactivity whereas fresh, intact RBCs are inert. With incubation, serum and platelet-rich plasma become inactive whereas the contractile activity of intact or h/sed RBCs persists. Similar experiments were performed in vivo by Mcllhany and colleagues, 35 who injected vasoactive fractions of hemoryzed RBCs, as collected on Sephadex G-75 gel filtration chromatography, into the cisterna magna of dogs. Vasoconstriction of the basilar artery was observed for 2 days. Peterson et al 42 found that RBC lysis was necessary for development of vasospasm after the subarachnoid injection of blood into dogs. In summary, during the time of vasospasm in man, the vasoactivity of blood incubated in vitro, when tested on the basilar artery in vitro, resides in RBCs. 
Studies of Cerebrospinal Fluid After Subarachnoid Hemorrhage
In man, vasospasm has its onset 3 days after SAH, peaks after 6-7 days, and resolves by 14 days. 46 This unusual time course could be explained by the spasmogen responsible for vasospasm exhibiting a similar time course of appearance in the CSF near arteries in spasm. An alternative hypothesis explains the delay in onset by suggesting that arterial narrowing is due to another mechanism such as fibrosis and inflammatory-cell infiltration of the arterial wall 47 or to intimal proliferation.
48
- 49 In our opinion, this latter hypothesis is untenable for a variety of reasons. There is no evidence that arterial wall area increases enough during vasospasm to narrow the lumen. 4849 Intimal proliferation and arterial wall fibrosis typically develop after vasospasm resolves. 49 Pathology of the subarachnoid space following human SAH shows that within 24 hours after SAH there is intense porymorphonuclear cell infiltration of the meninges. Phagocytosis and breakdown of RBCs occur by 16-32 hours. Breakdown of RBCs peaks around day 7 but continues for days, with clumps of intact RBCs still enmeshed in the arachnoid for up to 35 days after SAH. At 7 days, the inflammatory reaction subsides and is composed equally of lymphocytes and phagocytes. After 10 days, fibrosis of the subarachnoid space begins. Therefore, during the time of vasospasm, the most prominent process occurring in the subarachnoid space is RBC hemolysis.
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Clearance of blood injected into the subarachnoid space of animals is rapid, and most RBCs are removed by methods other than hemolysis.
-
53
-55 This is probably why single injections of liquid blood in experimental animals fail to mimic human vasospasm.
Hemolytic breakdown of RBCs observed microscopically may also be observed by spectrophotometric examination of pigments released into the CSF. Barrows and colleagues 17 used absorption spectrophotometry to examine CSF after SAH; OxyHb appeared 2 hours after SAH. By 4 days postictus bilirubin was present, and over the following week the amount of OxyHb decreased and that of bilirubin increased. In the absence of further bleeding, both pigments disappeared after 2-3 weeks. Bilirubin is present in normal serum and could be observed in the CSF immediately after massive SAH. In cases of SAH methemoglobin was not detected, although it is now believed to be present. Mayberg and colleagues 45 developed a piglet model of SAH that kept high concentrations of Hb or various blood components adjacent to the right MCA for 10 days. Pure porcine Hb (roughly 15% as OxyHb) resulted in a significant decrease in lumen area that was equal to that caused by RBC cytosol containing a similar amount of Hb. Although whole blood caused a greater decrease in lumen area than did Hb, these authors suggested that this was because the former was associated with more residual clotcontaining Hb at day 10. Therefore, all vasoactivity of the whole blood was accounted for by Hb.
In our laboratory, cynomolgus moiikeys had catheters placed along the right MCA and connected to subcutaneous CSF reservoirs. 6 In a randomized and controlled study of 40 monkeys, multiple intrathecal injections of OxyHb, methemoglobin, bilirubin, mock CSF, or supernatant fluid from an incubated mixture of autologous blood and mock CSF were given for 6 days. Significant vasospasm of the right MCA, as judged by comparison of angiograms taken at baseline and on day 7, developed in animals injected with OxyHb and supernatant fluid. Pure methemoglobin produced no significant arterial narrowing.
Mechanisms of Oxyhemoglobin-Induced Vasoconstriction Studies of How Oxyhemogbbin Causes Vasoconstriction
Contraction caused by receptor-operated systems usually decreases with time due to tachyphylaxis, desensitization, and/or autoregulation.
78
- 79 The time course of vasospasm suggests that smooth muscle contraction by a conventional receptor-operated system is not the sole mechanism responsible for arterial narrowing. Most agents suggested to be mediators of vasospasm, such as serotonin, biogenic amines, peptides, and eicosanoids, however, probably act on cell surface receptors. 45 - 79118 Further, antagonists of receptor-operated vasoconstrictors, including atropine, methysergide, cinanserin, ketanserin, phenoxybenzamine, phentolamine, mepyramine, chlorpheniramine, propranolol, saJbutamol, angiotensin, sarcosine, alanine, theophylline, and quinine, have consistently failed to reverse OxyHb-induced contractions of cerebral arteries in vitro and in 121 The latter are discussed in the next section. Although calcium channel antagonists partly reverse OxyHb-induced contraction of cerebral vessels in vitro, these drugs do not dilate monkey 122 or human 123124 cerebral arteries that are vasospastic. Kajikawa et al 108 - 109 found that after exposing rat basilar arteries in situ to barium chloride for 3 hours, papaverine did not dilate them, providing evidence that the duration of contraction bears upon the ability of pharmacological antagonists to relax smooth muscle.
OxyHb acutely increases the intracellular concentration of inositol phosphates, which are second messengers involved in smooth muscle contraction. 125 There are few other reports investigating the intracellular mechanism of action of OxyHb, which is obviously an important question.
Eicosanoids
Eicosanoids are products of enzymatic metabolism of arachidonic acid and include PGs, thromboxanes, and leukotrienes. 126 After SAH in monkeys and dogs, vasospastic vessels synthesize less PGI 2 Thus, although OxyHb affects vessel wall eicosanoid production and could account for the alteration in CSF levels of these substances after SAH, inhibitors of synthesis of PGs and thromboxanes do not prevent vasospasm. If OxyHb acts at multiple sites in the vessel wall (e.g., direct action on smooth muscle cells by the release of free radicals and the production of lipid peroxides, combined with the release of eicosanoids, EDRF, and endothelin from the endothelium), then antagonizing only one of these systems might not completely reverse the contraction. Furthermore, other factors, such as leukotrienes, which are also potent vasoactive agents and the concentrations of which increase after SAH, have not been thoroughly investigated.
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Free Radicals
OxyHb spontaneously autoxidizes to methemoglobin, releasing superoxide anion radical (O 2 "). Electrophysiological studies of isolated rat cerebral artery smooth muscle cells have shown OxyHb to activate calcium-dependent potassium currents and cause cell death. 84 Catalase protected cells from OxyHb, whereas superoxide dismutase did not. Xanthine and xanthine oxidase did not cause electrophysiological changes in cells, whereas the generation of hydroxyl radical in the bathing solution was damaging. The findings implicate the hydroxyl free radical rather than other oxygen free radicals although it may be difficult to define the actual free radicals involved based on such scavenger experiments. 152 In summary, superoxide dismutase and catalase alone are poor antagonists of OxyHb-induced cerebral artery contraction. There are several possible reasons for this. Free radical mechanisms may not be important or they may not be the sole pathway in the genesis of contraction by OxyHb. Superoxide dismutase and catalase may not be able to penetrate arterial walls to get to the locations where damaging free radical reactions occur. 152 Activity of both superoxide dismutase and a hydrogen peroxide scavenger may be necessary to prevent the genesis of oxygenderived free radicals since superoxide dismutase produces hydrogen peroxide, which can form hydroxyl radical in the presence of iron or ferrous proteins. 155 - 156 Catalase or glutathione peroxidase, if present, would catabolize hydrogen peroxide, preventing this reaction. Hydrogen peroxide 157 and iron ions 158 can also inhibit superoxide dismutase.
Endothelium-Dependent Relaxation
Furchgott and Zawadzki 159 showed that the vasodilatory action of acetylcholine on rabbit aorta was mediated by release of an intermediate substance from endothelial cells. This substance has been termed EDRF. Other vasodilators relax vascular smooth muscle through this endotheliumdependent mechanism, which has been subject to recent review. 160 After SAH in dogs, vasospastic basilar arteries contracted with PGF^ and uridine 5'-triphosphate exhibit impaired relaxation to arginine vasopressin and thrombin. 166 A study in vivo of endothelium-dependent relaxation and Hb was reported by Byrne et al. 113 In pigs, intracistenial injection of OxyHb caused acute vasoconstriction of intrathecal arteries. Intracarotid infusion of acetylcholine caused vasodilation before the intracisternal injection of OxyHb and vasoconstriction afterwards.
Kanamaru et al 120 found that xanthochromic CSF from SAH patients could inhibit A23187-induced endothelium-dependent relaxation in dog basilar artery in vitro. The levels of OxyHb in CSF correlated with the degree of inhibition of endothelium-dependent relaxation.
The ability of OxyHb to inhibit endothelium-dependent relaxation suggests that OxyHb is responsible for this event after SAH. How OxyHb prevents endothelium-dependent relaxation has been investigated. Both SAH and OxyHb damage arterial endothelium, possibly decreasing EDRF synthesis by endothelial cells.
1548
- 174 Kim et al, 161 however, used a bioassay system for EDRF to show that EDRF secretion by vasospastic dog basilar artery was not impaired. EDRF may be nitric oxide, 160 and Hb binds nitric oxide with an affinity 1,500 times higher than its affinity for oxygen. 175 Thus Hb, which presumably does not enter cells, could prevent EDRF, if it is nitric oxide, from entering smooth muscle cells and producing its effects.
The effects of OxyHb on EDRF have been assessed in vitro using more physiological systems that isolate the intraluminal and extraluminal aspects of the artery. Although OxyHb applied extraluminally to dog and rabbit cerebral arteries has been found to have little effect on endothelium-dependent relaxation, 170171 other researchers reported the inhibition of endothelium-derived responses after exposing extraluminal surfaces of cerebral arteries to OxyHb.
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The effects of Hb on endothelium are further complicated by observations that acetylcholine causes transient hyperpolarization and relaxation of rat aorta and guinea pig basilar artery precontracted by noradrenaline. 170 Hb prevents relaxation but doesn't alter hyperpolarization. It has been hypothesized that acetylcholine releases EDRF and endothelium-derived hyperpolarizing factor from endothelial cells.
In addition to EDRF, endothelium-derived hyperpolarizing factor, and eicosanoids, endothelial cells synthesize a potent vasoconstrictor peptide, endothelin. 176 Vasospasm is associated with increased CSF levels of endothelin. 177 -179 Findings that OxyHb augments the release of endothelin from cultured bovine cerebral artery endothelial cells suggest that OxyHb may be responsible for elevating CSF endothelin levels after SAH. 13 The importance of the endothelium in vasospasm remains unclear, although OxyHb contracts cerebral arteries denuded of endothelium, suggesting that endothelin release is not requisite for vasospasm. 96 . 99 . 100 . 103 . 119 . 180 Further, if the endothelium is removed after arteries are contracted with OxyHb, relaxation does not occur. 104 
Bilirubin
In 1949, Jackson 39 injected bilirubin into the cisterna magna of dogs, producing severe inflammatory reactions with fever, malaise, and increased CSF protein and leukocyte concentrations. The reaction was comparable to that induced by OxyHb, and he believed that one of these two agents caused hemogenic meningitis. Angiography was not done.
Several early experiments found that bilirubin had no effect on cerebral artery diameters in vitro. 105107 In these studies, bilirubin was applied to arteries for minutes only. Duff and colleagues 10 reported that bilirubin solutions caused progressive vasoconstriction of cat and baboon basilar arteries. Electron microscopy of the arteries showed swelling of endothelial cells, degeneration of axons and varicosities in the adventitia, and extensive vacuolation of smooth muscle and endothelial cells. These results were supported by investigations by Miao and Lee 11 that demonstrated the vasocontractile effects of bilirubin on cerebral arteries.
Intrathecal injection of bilirubin for 6 days was performed in our laboratory as part of a randomized trial to study the role of various blood components in the etiology of vasospasm in monkeys. 6 Bilirubin caused a nonsignificant 13% decrease in right MCA diameter. Ultrastructural examination of these arteries did show some pathological changes.
Although the time course of appearance of bilirubin in the CSF after SAH is similar to that of vasospasm, 17 -56 there are several reasons to doubt that bilirubin is an important spasmogen. Bilirubin contaminates CSF in other diseases such as neonatal and obstructive jaundice.
58 -181 - 183 Focal neurological deficits, which might be related to vasospasm, have rarely been noted in these conditions. 184 Wahlgren and Bergstrom 58 found concentrations of bilirubin in the CSF of patients with obstructive jaundice that caused vasospasm in the study of Duff et al. 10 Bilirubin, especially when bound to albumin, possesses antioxidant activity and inhibits lipid peroxidation. 183 -185186 Furthermore, in the subarachnoid space bilirubin is produced by an enzyme system with limited capacity, which may result in bilirubin concentrations that are too low to induce significant arterial narrowing after SAH. 187 Findings that intrathecal injections of OxyHb cause vasospasm whereas injections of methemoglobin do not also cast doubt on the bilirubin theory since both types of Hb produce bilirubin in the subarachnoid space.
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Neuwgenic Effects
Cerebral arteries receive adrenergic, cholinergic, and peptidergic innervation and possess receptors for neurotransmitters such as serotonin, a-and £-adrenergic drugs, dopamine, and histamine although the precise role of these nerves and receptors in the regulation of cerebrovascular tone is unknown. 188 -190 Adventitial nerve endings in cerebral arteries degenerate after experimental SAH, indicating that processes occur during vasospasm that are not simple muscular contraction. Regardless of the significance of these changes, if OxyHb causes vasospasm, then it should produce the particular arterial wall changes that have been observed in association with vasospasm.
Okada et al 15 injected OxyHb into feline prepontine cistern, causing myonecrosis, transformation of nerve endings, invasion of myointimal cells into the tunica intima, changes in endothelial cell basement membrane, and detachment of endothelial cells after 24 hours. Kajikawa and colleagues 108 -109 applied OxyHb to exposed rat basilar arteries for 3 hours. Vasospasm resulted, and at electron microscopy endothelial cell craters, blebs, and vacuoles were seen. Smooth muscle cells developed vacuoles, nuclear pyknosis, and mitochondrial degeneration. OxyHb caused vacuolation and degeneration of cultured rat aortic smooth muscle cells, whereas serotonin-and norepinephrine-exposed cells were normal.
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A spectrum of pathological changes have also been produced by the exposure of cerebral arteries in vivo to OxyHb. 6 -45 Therefore, OxyHb can produce morphological changes in cerebral arteries that are indistinguishable from those due to SAH.
Summary
There is good evidence that the release of OxyHb from lysing subarachnoid RBCs is a key mechanism responsible for vasospasm. OxyHb is present in high concentrations in CSF during the time of vasospasm. RBCs are the component of blood necessary for vasospasm to develop, and the most vasoactive substance within RBCs is OxyHb. Although it is not as potent a constrictor as some other agents, OxyHb can act by a variety of pathways over a prolonged period to produce arterial narrowing and ultrastructural damage to arteries that are akin to those occurring after SAH. While OxyHb may be the sole initiator of vasospasm, the pathogenesis of action of OxyHb is probably multifactorial, involving direct effects on smooth muscle, release of vasoactive eicosanoids and endothelin from the arterial wall, inhibition of endothelium-dependent relaxation, production of bilirubin and lipid peroxides, and damage to perivascular nerves.
The relative contributions of known mechanisms of action of OxyHb to the pathogenesis of vasospasm are not worked out. How OxyHb causes smooth muscle contraction and the biochemical derangements that it produces in smooth muscle are also key unanswered questions. 
